ATHENS – The Greek pharmaceutical company ELPEN is funding GRECCO-19, a clinical study which researches the active substance colchicine as a possible response treatment for […] The post Greek Pharmaceutical Company Funds Clinical Study of Colchicine as a Possible COVID-19 Treatment appeared first on The National Herald.
 |
| READ THE ORIGINAL POST AT www.thenationalherald.com |
